A5019079341- Pancreatic and Hepatic Oncology Research
- Esophageal and GI Pathology
- Esophageal Cancer Research and Treatment
- Neuroendocrine Tumor Research Advances
- Gastric Cancer Management and Outcomes
- Gastroesophageal reflux and treatments
- Pancreatitis Pathology and Treatment
- Dysphagia Assessment and Management
- Neuroblastoma Research and Treatments
- Gastrointestinal Tumor Research and Treatment
- Eosinophilic Esophagitis
- Nutrition and Health in Aging
- Tracheal and airway disorders
- Gastrointestinal disorders and treatments
- Renal cell carcinoma treatment
- Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Airway Management and Intubation Techniques
- COVID-19 and healthcare impacts
- Helicobacter pylori-related gastroenterology studies
- Sarcoma Diagnosis and Treatment
- Tuberculosis Research and Epidemiology
- Frailty in Older Adults
- Diagnosis and treatment of tuberculosis
University of Padua
2016-2025
IRCCS Policlinico San Donato
2024
Azienda Ospedaliera di Padova
2023
Hudson Institute
2021
John Wiley & Sons (United States)
2021
Virtual High School
2021
Veneto Institute of Molecular Medicine
2021
Creative Research Enterprises (United States)
2015
Daejeon St. Mary's Hospital
2013
Catholic University of Korea
2013
Neuromuscular junction remodeling and deterioration due to impaired BMP signaling are associated with cancer-induced muscle wasting.
Cachexia is a debilitating wasting syndrome and highly prevalent comorbidity in cancer patients. It manifests especially with energy mitochondrial metabolism aberrations that promote tissue wasting. We recently identified nicotinamide adenine dinucleotide (NAD+) loss to associate muscle dysfunction hosts. In this study we confirm depletion of NAD+ downregulation Nrk2, an biosynthetic enzyme, are common features severe cachexia different mouse models. Testing repletion therapy cachectic mice...
The pathophysiological and clinical value of performing High-Resolution Manometry (HRM) after laparoscopic fundoplication (LF) for gastroesophageal reflux disease (GERD) is still unclear debated.
There is no consensus on the definition of failure after treatment in patients with achalasia. The Eckardt score used to define clinical outcomes. However, objective metrics are lacking. This study aimed identify whether any high-resolution manometry (HRM) parameters may be useful predicting a positive outcome laparoscopic Heller-Dor (LHD).
Background Esophageal rhabdomyosarcoma is an exceedingly rare malignant tumor, with only three cases comprehensively documented in the literature since 1995. Due to its rarity, there limited information on epidemiology and diagnosis of this disease, no standardized treatment protocols have been established. As a result, both recognition management esophageal pose significant challenges. The present case report provides valuable insight into clinical approach highlighting need for further...
Esophageal cancer represents the 6th cause of mortality in World. New treatments led to outcome improvements, but patient selection and prognostic stratification is a critical aspect gain maximum benefit from therapies. Today, patients are stratified into 9 groups, according staging system developed by American Joint Committee on Cancer. Recently, trying better select with curing possibilities several authors reconsidering tumor length as valuable parameter. Specifically, endoscopic can be...